TP53 and cancer: To examine the possible involvement of PTEN as a positive feedback component to modulate p53 dynamics under the Nutlin-3a and/or 5-FU treatment, we first measured and compared the drug-induced PTEN upregulation levels in the five selected cancer cell lines.